Search Results

There are 26498 results for: content related to: Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial

  1. You have free access to this content
    In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines

    Veterinary and Comparative Oncology

    Volume 10, Issue 3, September 2012, Pages: 223–235, S. E. Lyles, R. J. Milner, K. Kow and M. E. Salute

    Article first published online : 18 MAY 2012, DOI: 10.1111/j.1476-5829.2012.00335.x

  2. Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells

    Veterinary and Comparative Oncology

    Volume 10, Issue 2, June 2012, Pages: 143–154, J. Lawrence, C. Saba, R. Gogal Jr, O. Lamberth, M. L. Vandenplas, D. J. Hurley, P. Dubreuil, O. Hermine, K. Dobbin and M. Turek

    Article first published online : 25 AUG 2011, DOI: 10.1111/j.1476-5829.2011.00291.x

  3. Masitinib mesylate for metastatic and non-resectable canine cutaneous mast cell tumours

    Veterinary and Comparative Oncology

    O. A. Smrkovski, L. Essick, B. W. Rohrbach and A. M. Legendre

    Article first published online : 12 JUL 2013, DOI: 10.1111/vco.12053

  4. A retrospective review of treatment and response of high-risk mast cell tumours in dogs

    Veterinary and Comparative Oncology

    R. L. Miller, S. Van Lelyveld, J. Warland, J. M. Dobson and R. D. Foale

    Article first published online : 15 SEP 2014, DOI: 10.1111/vco.12116

  5. You have full text access to this Open Access content
    Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors

    Journal of Veterinary Internal Medicine

    Volume 22, Issue 6, November–December 2008, Pages: 1301–1309, K.A. Hahn, G. Oglivie, T. Rusk, P. Devauchelle, A. Leblanc, A. Legendre, B. Powers, P.S. Leventhal, J.-P. Kinet, F. Palmerini, P. Dubreuil, A. Moussy and O. Hermine

    Article first published online : 24 SEP 2008, DOI: 10.1111/j.1939-1676.2008.0190.x

    Corrected by:

    ERRATUM

    Vol. 23, Issue 1, 224, Article first published online: 12 JAN 2009

  6. You have free access to this content
    A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008–2011 update

    Veterinary Dermatology

    Volume 24, Issue 1, February 2013, Pages: 97–e26, Thierry Olivry and Petra Bizikova

    Article first published online : 19 JAN 2013, DOI: 10.1111/j.1365-3164.2012.01088.x

  7. You have free access to this content
    Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics

    Allergy

    Volume 64, Issue 8, August 2009, Pages: 1194–1201, M. Humbert, F. De Blay, G. Garcia, A. Prud’homme, C. Leroyer, A. Magnan, J.-M. Tunon-de-Lara, C. Pison, M. Aubier, D. Charpin, I. Vachier, A. Purohit, P. Gineste, T. Bader, A. Moussy, O. Hermine and P. Chanez

    Article first published online : 8 JUL 2009, DOI: 10.1111/j.1398-9995.2009.02122.x

  8. Masitinib reverses doxorubicin resistance in canine lymphoid cells by inhibiting the function of P-glycoprotein

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 36, Issue 6, December 2013, Pages: 583–587, M. Zandvliet, E. Teske, T. Chapuis, J. Fink-Gremmels and J. A. Schrickx

    Article first published online : 31 JAN 2013, DOI: 10.1111/jvp.12039

  9. Abstracts presented at the 29th Annual VCS Conference, Austin, TX, USA, 16–19 October 2009

    Veterinary and Comparative Oncology

    Volume 8, Issue 2, June 2010, Pages: 153–233,

    Article first published online : 17 MAY 2010, DOI: 10.1111/j.1476-5829.2010.00214.x

  10. You have full text access to this Open Access content
    Safety of Masitinib Mesylate in Healthy Cats

    Journal of Veterinary Internal Medicine

    Volume 25, Issue 2, March/April 2011, Pages: 297–302, M. Daly, S. Sheppard, N. Cohen, M. Nabity, A. Moussy, O. Hermine and H. Wilson

    Article first published online : 11 FEB 2011, DOI: 10.1111/j.1939-1676.2011.0687.x

  11. Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor

    European Journal of Haematology

    Volume 89, Issue 1, July 2012, Pages: 47–52, Sophie Georgin-Lavialle, Ludovic Lhermitte, Felipe Suarez, Ying Yang, Sébastien Letard, Katia Hanssens, Frédéric Feger, Amédée Renand, Chantal Brouze, Danielle Canioni, Vahid Asnafi, Marie-Olivia Chandesris, Achille Aouba, Paul Gineste, Elizabeth Macintyre, Colin D. Mansfield, Alain Moussy, Yves Lepelletier, Patrice Dubreuil and Olivier Hermine

    Article first published online : 28 APR 2012, DOI: 10.1111/j.1600-0609.2012.01761.x

  12. Receptor tyrosine kinase inhibitors: molecularly targeted drugs for veterinary cancer therapy

    Veterinary and Comparative Oncology

    Volume 10, Issue 3, September 2012, Pages: 163–173, S. Bavcar and D. J. Argyle

    Article first published online : 6 AUG 2012, DOI: 10.1111/j.1476-5829.2012.00342.x

  13. You have free access to this content
    Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study

    American Journal of Hematology

    Volume 85, Issue 12, December 2010, Pages: 921–925, Carle Paul, Beatrix Sans, Felipe Suarez, Philippe Casassus, Stéphane Barete, Fanny Lanternier, Catherine Grandpeix-Guyodo, Patrice Dubreuil, Fabienne Palmérini, Colin D. Mansfield, Paul Gineste, Alain Moussy, Olivier Hermine and Olivier Lortholary

    Article first published online : 23 NOV 2010, DOI: 10.1002/ajh.21894

  14. Kinase dysfunction and kinase inhibitors

    Veterinary Dermatology

    Volume 24, Issue 1, February 2013, Pages: 181–e40, Cheryl A. London

    Article first published online : 19 JAN 2013, DOI: 10.1111/j.1365-3164.2012.01081.x

  15. You have free access to this content
    European consensus document on mast cell tumours in dogs and cats

    Veterinary and Comparative Oncology

    Volume 10, Issue 3, September 2012, Pages: e1–e29, L. Blackwood, S. Murphy, P. Buracco, J. P. De Vos, P. De Fornel-Thibaud, J. Hirschberger, M. Kessler, J. Pastor, F. Ponce, K. Savary-Bataille and D. J. Argyle

    Article first published online : 6 AUG 2012, DOI: 10.1111/j.1476-5829.2012.00341.x

  16. You have full text access to this OnlineOpen article
    NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation

    Allergy

    Volume 67, Issue 7, July 2012, Pages: 858–868, E. Hadzijusufovic, B. Peter, H. Herrmann, T. Rülicke, S. Cerny-Reiterer, K. Schuch, L. Kenner, T. Thaiwong, V. Yuzbasiyan-Gurkan, W. F. Pickl, M. Willmann and P. Valent

    Article first published online : 15 MAY 2012, DOI: 10.1111/j.1398-9995.2012.02833.x

  17. Systemic therapy for advanced gastrointestinal stromal tumors: Beyond imatinib

    Journal of Surgical Oncology

    Volume 104, Issue 8, 15 December 2011, Pages: 901–906, Edward J. Kim and Mark M. Zalupski

    Article first published online : 8 NOV 2011, DOI: 10.1002/jso.21872

  18. You have full text access to this Open Access content
    Drug-Induced Minimal Change Nephropathy in a Dog

    Journal of Veterinary Internal Medicine

    Volume 24, Issue 2, March/April 2010, Pages: 431–435, S.O. Sum, P. Hensel, L. Rios, S. Brown, E.W. Howerth, E.A. Driskell, A. Moussy, O. Hermine and C.A. Brown

    Article first published online : 29 JAN 2010, DOI: 10.1111/j.1939-1676.2010.0471.x

  19. Biological effect of tyrosine kinase inhibitors on three canine mast cell tumor cell lines with various KIT statuses

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 35, Issue 1, February 2012, Pages: 97–104, Y. TAKEUCHI, Y. FUJINO, K. FUKUSHIMA, M. WATANABE, T. NAKAGAWA, K. OHNO, N. SASAKI, S. SUGANO and H. TSUJIMOTO

    Article first published online : 12 APR 2011, DOI: 10.1111/j.1365-2885.2011.01296.x

  20. SMALL ANIMAL REVIEW

    Companion Animal

    Volume 16, Issue 1, January/February 2011, Page: 15,

    Article first published online : 15 FEB 2011, DOI: 10.1111/j.2044-3862.2010.00006.x